Endocrinology & Metabolic

GLP-1 Drug Coverage for Type 1 Diabetes

Sonia Reyes
Cardiology, Endocrinology & Metabolic, Clinical Trial Updates | Jul 7, 2026
An emulated-trial study of 174,678 adults with type 1 diabetes links GLP-1 receptor agonist use to lower risks of major cardiac events and kidney failure.

Dr. Denise Yardley Interprets ASCO GLP-1 & Metastatic Breast Cancer Abstract Findings

Sonia Reyes
Oncology Care, Podcasts, Healthcare Headlines, Breast Cancer, Endocrinology & Metabolic | Jun 29, 2026
Dr. Denise Yardley of SCRI interpreted observational data presented at ASCO 2026, indicating that breast cancer patients on GLP-1 medications may progress to metastatic disease at approximately half the rate of those on older diabetes treatments.

New Guideline Addresses CKM Syndrome

Sonia Reyes
Specialty Medicine, Cardiology, Endocrinology & Metabolic | Jun 18, 2026
The 2026 AHA/ACC/ADA/ASN guideline reframes obesity, diabetes, kidney, and cardiovascular disease as one staged syndrome and ties treatment intensity to risk.

Cannabis Extracts and the Metabolic Paradox: Insights into Obesity and Glucose Control

George Padron
Specialty Medicine, Endocrinology & Metabolic | Jun 4, 2026
In diet-induced obese mice, cannabis extracts, more than THC alone, reduced fat and improved glucose homeostasis, a preclinical signal.

Patient Selection as the Pivot: Bariatric Surgery Coverage After 65

George Padron
Specialty Medicine, Endocrinology & Metabolic, Access & Affordability, Prior Authorization, Coverage & Appeals, Managed Care | Jun 1, 2026
A Vienna cohort of 111 adults 65+ found bariatric surgery drove durable weight loss and comorbidity remission over 5 years, but with a ~9% reoperation rate.